The US Supreme Court blocked lower-court restrictions on mifepristone to ensure continued nationwide access.A 7-2 vote overturned an appeals court ruling that had sought to ban telehealth prescriptions and mail deliveries.The case follows a lawsuit by Louisiana challenging the FDA authority to regulate the drug after state-level bans.Justices
Clarence Thomas and
Samuel Alito dissented from the majority decision to keep current distribution rules intact.